SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-136688
Filing Date
2018-04-27
Accepted
2018-04-27 07:52:56
Documents
2
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d279709ddefa14a.htm DEFA14A 15395
2 GRAPHIC g2797091.jpg GRAPHIC 317790
  Complete submission text file 0001193125-18-136688.txt   450830
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37783 | Film No.: 18781016
SIC: 2834 Pharmaceutical Preparations